Elisabet Hjerpe

709 total citations
19 papers, 514 citations indexed

About

Elisabet Hjerpe is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, Elisabet Hjerpe has authored 19 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Obstetrics and Gynecology, 9 papers in Reproductive Medicine and 7 papers in Oncology. Recurrent topics in Elisabet Hjerpe's work include Endometrial and Cervical Cancer Treatments (9 papers), Ovarian cancer diagnosis and treatment (8 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Elisabet Hjerpe is often cited by papers focused on Endometrial and Cervical Cancer Treatments (9 papers), Ovarian cancer diagnosis and treatment (8 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Elisabet Hjerpe collaborates with scholars based in Sweden, Finland and Norway. Elisabet Hjerpe's co-authors include Elisabeth Åvall‐Lundqvist, Maria C. Shoshan, Joseph W. Carlson, Elisabeth Åvall Lundqvist, Per Rosenberg, Karin Stålberg, Erik Holmberg, Bengt Tholander, Pernilla Dahm‐Kähler and Kristina Hellman and has published in prestigious journals such as Cancer Research, British Journal of Cancer and Molecular Cancer Therapeutics.

In The Last Decade

Elisabet Hjerpe

19 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabet Hjerpe Sweden 13 201 173 170 155 97 19 514
Susan B. Ingersoll United States 8 144 0.7× 144 0.8× 113 0.7× 137 0.9× 67 0.7× 21 516
Phil Rolland United Kingdom 10 190 0.9× 229 1.3× 144 0.8× 137 0.9× 88 0.9× 11 582
Satoshi Tsunetoh Japan 15 280 1.4× 243 1.4× 235 1.4× 188 1.2× 159 1.6× 32 715
Mingzi Tan China 16 339 1.7× 125 0.7× 145 0.9× 57 0.4× 176 1.8× 28 615
Eleonora Zaccarelli Italy 8 172 0.9× 205 1.2× 129 0.8× 57 0.4× 81 0.8× 13 418
Jun Naniwa Japan 13 223 1.1× 114 0.7× 158 0.9× 75 0.5× 53 0.5× 19 399
Jennifer Veneris United States 11 174 0.9× 250 1.4× 162 1.0× 106 0.7× 73 0.8× 33 492
Wenyan Wang China 16 232 1.2× 90 0.5× 78 0.5× 68 0.4× 177 1.8× 44 541
Daphne Gschwantler‐Kaulich Austria 14 203 1.0× 250 1.4× 93 0.5× 37 0.2× 153 1.6× 50 636
Naoki Ogane Japan 14 205 1.0× 116 0.7× 104 0.6× 72 0.5× 160 1.6× 26 437

Countries citing papers authored by Elisabet Hjerpe

Since Specialization
Citations

This map shows the geographic impact of Elisabet Hjerpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabet Hjerpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabet Hjerpe more than expected).

Fields of papers citing papers by Elisabet Hjerpe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabet Hjerpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabet Hjerpe. The network helps show where Elisabet Hjerpe may publish in the future.

Co-authorship network of co-authors of Elisabet Hjerpe

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabet Hjerpe. A scholar is included among the top collaborators of Elisabet Hjerpe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabet Hjerpe. Elisabet Hjerpe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Borgfeldt, Christer, Erik Holmberg, Janusz Marcickiewicz, et al.. (2021). Survival in endometrial cancer in relation to minimally invasive surgery or open surgery – a Swedish Gynecologic Cancer Group (SweGCG) study. BMC Cancer. 21(1). 658–658. 6 indexed citations
2.
Törngren, Therese, Anders Kvist, Georgia Kokaraki, et al.. (2021). Precision Oncology of High-Grade Ovarian Cancer Defined through Targeted Sequencing. Cancers. 13(20). 5240–5240. 3 indexed citations
3.
Dahm‐Kähler, Pernilla, Erik Holmberg, Angelique Flöter Rådestad, et al.. (2021). Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG study. Gynecologic Oncology. 161(1). 244–250. 7 indexed citations
4.
Peuget, Sylvain, Jiawei Zhu, Gema Sanz, et al.. (2020). Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds. Cancer Research. 80(7). 1538–1550. 14 indexed citations
5.
Moyano‐Galceran, Lidia, Elina Pietilä, S. Pauliina Turunen, et al.. (2020). Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer. EMBO Molecular Medicine. 12(4). e11177–e11177. 40 indexed citations
6.
Hellman, Kristina, Erik Holmberg, Maria Bjurberg, et al.. (2020). Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma: A population-based SweGCG study. Gynecologic Oncology. 159(3). 663–671. 14 indexed citations
7.
Bjurberg, Maria, Erik Holmberg, Christer Borgfeldt, et al.. (2019). Primary treatment patterns and survival of cervical cancer in Sweden: A population-based Swedish Gynecologic Cancer Group Study. Gynecologic Oncology. 155(2). 229–236. 15 indexed citations
8.
Stålberg, Karin, Maria Bjurberg, Christer Borgfeldt, et al.. (2019). Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer – a Swedish Gynecologic Cancer Group (SweGCG) study. Acta Oncologica. 58(11). 1628–1633. 63 indexed citations
9.
Lindemann, Kristina, Emma Gibbs, Elisabeth Åvall‐Lundqvist, et al.. (2017). Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist). British Journal of Cancer. 116(4). 455–463. 36 indexed citations
10.
Hjerpe, Elisabet, Christian Staf, Pernilla Dahm‐Kähler, et al.. (2017). Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease – a Swedish Gynecologic Cancer Group (SweGCG) study. Acta Oncologica. 57(3). 331–337. 21 indexed citations
11.
Salehi, Sahar, Takayuki Suzuki, Ulrika Joneborg, et al.. (2017). Cardiophrenic lymph node resection in advanced ovarian cancer: surgical outcomes, pre- and postoperative imaging. Acta Oncologica. 57(6). 820–824. 10 indexed citations
12.
Rosenberg, Per, Preben Kjølhede, Christian Staf, et al.. (2017). Data quality in the Swedish Quality Register of Gynecologic Cancer – a Swedish Gynecologic Cancer Group (SweGCG) study. Acta Oncologica. 57(3). 346–353. 42 indexed citations
13.
Malander, Susanne, Elisabet Hjerpe, Joseph W. Carlson, & Åke Borg. (2015). [Ovarian cancer is in many ways a heterogeneous disease].. PubMed. 112. 2 indexed citations
14.
Hjerpe, Elisabet, Suzanne Egyházi Brage, Marianne Frostvik Stolt, et al.. (2014). Metabolic Markers and HSP60 in Chemonaive Serous Solid Ovarian Cancer Versus Ascites. International Journal of Gynecological Cancer. 24(8). 1389–1394. 6 indexed citations
15.
Hjerpe, Elisabet, Suzanne Egyházi, Joseph W. Carlson, et al.. (2013). HSP60 Predicts Survival in Advanced Serous Ovarian Cancer. International Journal of Gynecological Cancer. 23(3). 448–455. 43 indexed citations
16.
Hjerpe, Elisabet, Søren Brage, Joseph W. Carlson, et al.. (2013). Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer. BMC Clinical Pathology. 13(1). 37 indexed citations
17.
Leandro‐García, Luis J., Lucía Inglada‐Pérez, Guillermo Pita, et al.. (2013). Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy. Journal of Medical Genetics. 50(9). 599–605. 66 indexed citations
18.
19.
Hernlund, E, Elisabet Hjerpe, Elisabeth Åvall‐Lundqvist, & Maria C. Shoshan. (2009). Ovarian carcinoma cells with low levels of β-F1-ATPase are sensitive to combined platinum and 2-deoxy-d-glucose treatment. Molecular Cancer Therapeutics. 8(7). 1916–1923. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan B. Ingersoll Breakdown of academic impact, for papers by Phil Rolland Breakdown of academic impact, for papers by Satoshi Tsunetoh Breakdown of academic impact, for papers by Mingzi Tan Breakdown of academic impact, for papers by Eleonora Zaccarelli Breakdown of academic impact, for papers by Jun Naniwa Breakdown of academic impact, for papers by Jennifer Veneris Breakdown of academic impact, for papers by Wenyan Wang Breakdown of academic impact, for papers by Daphne Gschwantler‐Kaulich Breakdown of academic impact, for papers by Naoki Ogane
Rankless by CCL
2026